Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.01852-24 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Valentina Milanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Daye, London, United Kingdom. Hauptthemen laut MEDLINE: Menstrual Hygiene Products, Vaginal Smears, Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer screening is vital for achieving global elimination of this preventable disease. Vaginal self-sampling (VSS) for human papillomavirus (HPV) has the potential to increase screening uptake, particularly among individuals who may be underserved by clinician collection. Expanding self-sampling options with accurate, acceptable collection devices is essential. The Daye diagnostic tampon (DDT) offers an innovative approach, utilizing a tampon for HPV-based detection. This study assessed the diagnostic accuracy of DDT in detecting high-risk HPV infections, using vaginal clinician-collected swabs (CCS) as the reference standard. In this UK-based study, 260 participants provided CCS and VSS (with Copan FLOQSwabs) and DDT samples for HPV testing. Samples were analyzed using the Aptima HPV assay, which detects 14 high-risk HPV types. The sensitivity, specificity, positive predictive value, and negative predictive value of the DDT were evaluated against the CCS. Invalidity rates—HPV-negative results with negative internal controls—were compared across sampling methods. The DDT showed a sensitivity of 82.9% [95% confidence interval (CI): 72.4%–89.9%], specificity of 91.6% (CI: 86.4%–94.9%), and overall accuracy of 89.0% (CI: 84.4%–92.4%) relative to CCS. McNemar’s test showed no significant difference between CCS and DDT results ( P = 0.845). Valid result rates were highest for DDT (99.2%), followed by VSS (95.4%) and CCS (90.8%). The DDT demonstrates comparable accuracy to CCS for detecting high-risk HPV. This novel device shows promise as a self-sampling method. Furthermore, complementary research should focus on assessing DDT’s clinical performance in detecting HPV associated with cervical disease endpoints. IMPORTANCE Cervical cancer remains a leading preventable cause of cancer death globally, with persistent disparities in screening access. Self-sampling for HPV has emerged as a critical tool to improve screening uptake, particularly among underserved populations, yet device acceptability and diagnostic reliability remain barriers to equitable implementation. This study demonstrates that the Daye diagnostic tampon (DDT), a novel, tampon-based self-sampling method, achieves diagnostic accuracy comparable to clinician-collected swabs (sensitivity 82.9% and specificity 91.6%) while yielding fewer invalid results (0.8%) than conventional swabs. By aligning with a familiar menstrual product, the DDT addresses usability concerns that hinder confidence in existing self-sampling devices, as evidenced by 70.5% participant preference in focus groups. These findings advance progress toward World Health Organisation (WHO) cervical cancer elimination targets by validating a culturally resonant, high-performance alternative to clinic-based sampling. The DDT’s potential to expand screening access, especially in low-resource settings or among individuals avoiding pelvic exams, could transform preventive care landscapes, reducing disparities in a disease rooted in healthcare inequity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Daye, London, United Kingdom.
- Lindus Health, London, United Kingdom.
- TotaEffects GmH, Oranienburg, Germany.
- Center for Reproductive Health, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
- Independent consultant, London, United Kingdom.
ORCID-Profile: Michelle Gomes, Hannah McCulloch, Kate Cuschieri
Zitieren
APA
Milanova, V., Gomes, M., Mihaylova, K., Twelves, J. L., Multmeier, J., McMahon, H., McCulloch, H., & Cuschieri, K. (2025). Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01852-24
Vancouver
Milanova V, Gomes M, Mihaylova K, Twelves JL, Multmeier J, McMahon H, et al. Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.01852-24
BibTeX
@article{Milanova2025,
author = {Milanova, Valentina and Gomes, Michelle and Mihaylova, Kalina and Twelves, John Luke and Multmeier, Jan and McMahon, Hana and McCulloch, Hannah and Cuschieri, Kate},
title = {Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.01852-24}
}
EUVIMED